Is There A Clinical Connection Between Opioid Use And Breast Cancer Recurrence?
the Clinical Pain Advisor take:
Physicians prescribing opioids have received a lot of flak lately -- especially from those in the media and the medical community. Clinicians working with breast cancer patients, however, may prescribe narcotics for those suffering from mild to severe pain -- it's not an uncommon practice. This approach led one group of researchers to find out if there's a connection between opioid use and the recurrence of cancer.
The good news: Evidence revealed that there is no connection. Published in Cancer, a recent Danish study used the Danish Breast Cancer Cooperative Group (DBCG) Registry to collect patient data. Researchers selected patients with incident, early-stage breast cancer who were diagnosed between 1996 and 2008. The study's authors then cross-matched participants with opioid prescriptions from the Danish National Prescription Registry.
To compute hazard ratios, researchers used Cox regression models. There were 34,188 patients who met the study's criteria. Analysis of the data revealed that there was no association between patients who had used opioids and breast cancer recurrence. The reason why this was originally looked at is opioids may alter immune function, thereby potentially affecting cancer recurrence.
"Breast cancer recurrence rates were lower among users of strongly (but not weakly) immunosuppressive opioids, possibly because of channeling bias among those with a high competing risk, because mortality was higher among users of this drug type," the study's authors said.
The Centers for Disease Control and Prevention (CDC) earlier in the year reported that there were 16,235 deaths involving prescription opioids in 2013, an increase of 1% from 2012.
Researchers selected patients with incident, early-stage breast cancer who were diagnosed between 1996 and 2008.
Clinical Pain Advisor Articles
- Replacing Sleep, Sedentary Behavior With Physical Activity Beneficial in Knee Osteoarthritis
- FDA Outlines Plan for New Analgesic Guidance to Combat Opioid Crisis
- The Role of Psychological Factors in Phantom Limb Pain Reviewed
- Rates of Concurrent Opioid, Sedative-Hypnotic Prescription Fills in Veterans
- Ozone vs Corticosteroids May Provide Longer-Lasting Effects for Plantar Fasciitis
- Ketamine: Mechanisms of Action, Uses in Pain Medicine, and Side Effects
- Medicinal Cannabis May Not Have Opioid-Sparing Effects in Chronic Noncancer Pain
- Cannabis May Be Effective for Migraine Treatment
- Integrating Psychological Interventions Into Chronic Pain Management
- Chronic Neck Pain: Generators, Clinical Examination, MRI Findings, and Differential Diagnosis
- Pregabalin May Not Improve Analgesia During Medical Abortion
- Investigational Treatment Shows Promise in Chronic Low Back Pain
- Rheumatologist-Assessed vs Criteria for Inflammatory Back Pain in Psoriatic Arthritis
- Incorporating Guidelines Into Clinical Practice: An Interview With Gary L. LeRoy, MD
- Pain Severity May Partly Mediate the Association Between Depression and Physical Performance in Knee OA